According to the Zhitong Finance App, Dongrui Pharmaceutical (02348) announced that on November 12, 2026, the company spent HK$203,300 to repurchase 220,000 shares at a repurchase price of HK$0.91 to HK$0.915 per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.